tiprankstipranks
Trending News
More News >
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
India Market

Orchid Pharma Limited (ORCHPHARMA) Income Statement

Compare
0 Followers

Orchid Pharma Limited Income Statement

Last quarter (Q3 2025), Orchid Pharma Limited's total revenue was ₹2.17B, a decrease of -1.47% from the same quarter last year. In Q3, Orchid Pharma Limited's net income was ₹207.75M. See Orchid Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 9.22B₹ 8.19B₹ 6.66B₹ 5.60B₹ 4.50B
Gross Profit
₹ 3.78B₹ 3.16B₹ 2.65B₹ 2.32B₹ 2.09B
Operating Expenses
₹ 1.74B₹ 2.42B₹ 2.39B₹ 2.66B₹ 2.60B
Depreciation and Amortization
₹ 345.46M₹ 332.37M₹ 547.87M₹ 870.25M₹ 1.09B
EBITDA
₹ 1.45B₹ 1.42B₹ 1.43B₹ 635.82M₹ 658.74M
Operating Income
₹ 2.57B₹ 784.69M₹ 296.69M₹ -338.90M₹ -504.94M
Other Income/Expenses
₹ -1.61B₹ 134.76M₹ 255.78M₹ -230.09M₹ -447.55M
Pretax Income
₹ 955.65M₹ 919.45M₹ 552.47M₹ -568.99M₹ -952.49M
Net Income
₹ 996.57M₹ 921.66M₹ 463.18M₹ -19.51M₹ -1.17B
Per Share Metrics
Basic EPS
₹ 19.65₹ 19.06₹ 11.35₹ -0.48₹ -28.55
Diluted EPS
₹ 19.65₹ 19.06₹ 11.35₹ -0.48₹ -28.55
Weighted Average Shares Outstanding
50.72M 48.37M 40.82M 40.82M 40.82M
Weighted Average Shares Outstanding (Diluted)
50.72M 48.37M 40.82M 40.82M 40.82M
Currency in INR

Orchid Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis